BeOne Medicines (BEIGF) Retained Earnings (2015 - 2026)
BeOne Medicines (BEIGF) reported Retained Earnings of -$8.1 billion for Q1 2026, down 5586.12% year-over-year from $147.5 million in Q1 2025, and up 2.73% quarter-over-quarter from -$8.3 billion in Q4 2025.
BeOne Medicines (BEIGF) Retained Earnings (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of Retained Earnings data on file, last reported at -$8.1 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$8.1 billion, down 5586.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.1 billion (down 5586.12% YoY), and the FY2025 annual result was -$8.3 billion, up 3.33% from the prior year.
- Retained Earnings advanced to -$8.1 billion in Q1 2026 per BEIGF's latest filing, from -$8.3 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $17.5 million in Q1 2022 and troughed at -$8.6 billion in Q4 2024.
- A 5-year average of -$3.8 billion and a median of -$161.5 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings soared 444.76% in 2022, then slumped 42662.01% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$77.4 million in 2022, then fell by 28.45% to -$99.4 million in 2023, then tumbled by 8554.78% to -$8.6 billion in 2024, then increased by 3.33% to -$8.3 billion in 2025, then gained by 2.73% to -$8.1 billion in 2026.
- Business Quant data shows BEIGF's Retained Earnings at -$8.1 billion in Q1 2026, -$8.3 billion in Q4 2025, and -$101.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -838.07 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | -8.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.09 Bn |
| Dec 31, 2025 | -8.32 Bn |
| Sep 30, 2025 | -101.26 Mn |
| Jun 30, 2025 | -113.70 Mn |
| Mar 31, 2025 | -142.32 Mn |
| Dec 31, 2024 | -8.61 Bn |
| Sep 30, 2024 | -8.45 Bn |
| Jun 30, 2024 | -140.47 Mn |
| Mar 31, 2024 | -8.21 Bn |
| Dec 31, 2023 | -99.45 Mn |
| Sep 30, 2023 | -7.59 Bn |
| Jun 30, 2023 | -7.81 Bn |
| Mar 31, 2023 | -7.43 Bn |
| Dec 31, 2022 | -77.42 Mn |
| Sep 30, 2022 | -161.52 Mn |
| Jun 30, 2022 | -82.45 Mn |
| Mar 31, 2022 | 17.45 Mn |
| Dec 31, 2021 | 17.95 Mn |
| Sep 30, 2021 | 12.58 Mn |
| Jun 30, 2021 | -3.97 Bn |